Trial intelligence / Profile preview

Anesthetic Method and Recurrence in NMIBC

NCT03597087Phase 2Unknown

Sponsor
Seoul National University Hospital
Start
Jul 2018
Primary completion
Jul 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of propofol, bupivacaine in bladder cancer, sponsored by Seoul National University Hospital. Status: unknown.

02

Drugs

propofolbupivacaine
03

Conditions

bladder cancer

Beyond the preview

Go deeper on NCT03597087.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03597087.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call